Moderna Surges On COVID-19 Vaccine News, M&A: The Biggest Deal Of The Year, And Nikola Shares Get Unplugged By GM

Squawk on the Street

On the final trading day of what has been a strong November for stocks, Carl Quintanilla, Jim Cramer and David Faber discussed the latest vaccine developments from Moderna: The company's shares surging on new data showing its COVID-19 vaccine candidate is more than 94-percent effective and was safe. Moderna also says it will ask the FDA to authorize the vaccine for emergency use. On the M&A front: Wall Street data giants S&P Global and IHS Markit agreed to merge in a $44-billion transaction - the biggest deal of the year. Shares of Slack surged on a David Faber report surrounding a potential Salesforce-Slack deal. The anchors also weighed in on shares of Nikola tumbling on news that General Motors will no longer take an equity stake in the electric truck maker. Also in focus: The Biden transition team confirming the former Fed Chair Janet Yellen would be the President-elect's nominee for Treasury Secretary.